Allergan (AGN) Tops Q4 EPS by 5c

Allergan (NYSE: AGN) reported Q4 EPS of $3.41, $0.05 better than the analyst estimate of $3.36. Revenue for the quarter came in at $4.2 billion versus the consensus estimate of $4.2 billion.

GUIDANCE:

Allergan sees FY2016 revenue of abot $17 billion, versus the consensus of $17.66 billion.

For earnings history and earnings-related data on Allergan (AGN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group